Information:
Error:
Keywords
Concomitant Medication ×
- Clinical Trial (346)
- Adverse event (124)
- Clinical Trial, Phase III (91)
- Restless Legs Syndrome (77)
- Neurology (77)
- Vaccination (70)
- Vital Signs (52)
- Drug trial (34)
- Parkinsons Disease (33)
- Vaccines (30)
- Symptom Assessment (29)
- Hepatitis B Vaccines (28)
- Diaries (28)
- Hepatitis B (28)
- Laboratories (28)
- Haemophilus influenzae type b (26)
- Clinical Trial, Phase II (22)
- Medical History Taking (22)
- Therapeutics (21)
- Physical Examination (20)
- Pharmacokinetics (19)
- Meningococcal Vaccines (18)
- Hematology (18)
- Hypereosinophilic Syndrome (17)
- Eligibility Determination (17)
- Clinical Trial, Phase I (16)
- Asthma (15)
- Electrocardiogram (ECG) (15)
- Neisseria meningitidis (14)
- Signs and Symptoms (13)
- Migraine Disorders (13)
- Pulmonary Medicine (12)
- Gynecology (12)
- Medical Oncology (12)
- Ophthalmology (12)
- On-Study Form (11)
- Hepatitis A (11)
- Safety (10)
- Drugs, Investigational (10)
- Scores & Instruments (10)
- Alzheimer Disease (10)
- Follow-Up Studies (10)
- Malaria Vaccines (9)
- Breast Neoplasms (9)
- Pulmonary Disease, Chronic Obstructive (9)
- Drug-Related Side Effects and Adverse Reactions (9)
- Drug Administration Routes (9)
- Influenza Vaccines (9)
- Medical Records (9)
- Multiple Myeloma (9)
- Clinical Trial, Phase IV (8)
- Hepatitis A Vaccines (8)
- Child (8)
- Compliance (8)
- Demography (8)
- Gastroenterology (8)
- Tetanus (7)
- Urinalysis (7)
- Multiple System Atrophy (7)
- Trial screening (7)
- End of Study (7)
- Diphtheria (7)
- Malaria (7)
- Meningitis, Meningococcal (7)
- Pharmacogenetics (6)
- Psychiatry (6)
- Bordetella pertussis (6)
- Chickenpox Vaccine (6)
- Diphtheria-Tetanus-acellular Pertussis Vaccines (6)
- Routine documentation (6)
- Diabetes Mellitus, Type 2 (6)
- Drug Therapy (6)
- Parkinson Disease (6)
- Pregnancy (5)
- Schizophrenia (5)
- Diphtheria-Tetanus-Pertussis Vaccine (5)
- Sumatriptan (5)
- Measles-Mumps-Rubella Vaccine (5)
- Treatment Form (5)
- Diabetes Mellitus (5)
- Hypertension (5)
- Infection (5)
- Patient Participation (5)
- Risk Factors (4)
- Rotavirus (4)
- Chemotherapy, Adjuvant (4)
- Cross-Over Studies (4)
- Topotecan (4)
- Case Reports (4)
- AML (4)
- Chest X- ray (4)
- Non Small Cell Lung Cancer (4)
- Released Standard (4)
- Depressive Disorder (4)
- Pharmaceutical Preparations (4)
- Lung Neoplasms (4)
- Macular Edema (4)
- Neurologic Examination (4)
- Ovarian Neoplasms (4)
Table of contents
Selected data models
You must log in to select data models for download or further analysis.
467 Search results.
Itemgroups: Adverse Events,Concomitant Medication,Demographics,Disease Characteristics,Disposition,ECG,Laboratory,Laboratory Data,Medical History,Patient Reported Outcome,Substance Use,Surgery,Tumor Response,Vital Signs
Itemgroups: Current episode,Diagnosis,Current medication
Itemgroups: General information,Details
Itemgroup: Subject details
On-Treatment 1
15 itemgroups 84 itemsOn-Treatment 2
13 itemgroups 62 itemsOn-Treatment 4
12 itemgroups 62 items Itemgroups: Administrative,Prior Medication,Prior Medication
Itemgroups: Date of visit/ assessment,Adverse event | Concomitant Medication Ongoing | Evaluation,Pharmaceutical Preparations Concomitant Therapy
Itemgroups: Administration,Glucose Assay,Glucose Assay,Plasma Drug Assay,Plasma Drug Assay,Volunteer Completion/Withdrawal,Investigator's checklist,Investigator's Statement,Concominant Medication,Missing Data,Missing Data,Missing Data,Missing Data
Itemgroups: Date of visit, Assessment Date,Adverse Event; Concomitant Agent; Evaluation, Repeat,Liver, Adverse Event,Non-serious Adverse Event,Serious Adverse Event,Concomitant Agent,Laboratory Procedures,Vital signs,Pharmacokinetic aspect, Blood, Repeat,Pulmonary function tests, Repeat,Holter Electrocardiography, Repeat,Holter Electrocardiography, Abnormality, Repeat,Telemetry, Repeat,Telemetry, Abnormality, Repeat,12 lead ECG, Abnormality, Repeat,12 lead ECG
Itemgroups: Note,Inclusion Criteria,Exclusion Criteria,Physical examination,Pregnancy test,Alcohol test,Urine drug screening,orthostatic blood pressure / Pulse - Predose,Concomitant medication,Adverse event,Patient diary,Randomization,High fat breakfast,Study Drug Dosing,Orthostatic blood pressure / pulse measurement - post dose,Adverse Event - post dosing,Pharmacokinetic sampling post dosing,Discharge
Itemgroups: Note,Inclusion Criteria,Exclusion Criteria,Physical examination,orthostatic blood pressure / Pulse - Predose,Pregnancy test,Patient diary,Alcohol test,Urine drug screening,Concomitant medication,Adverse event,Randomization,Standard Breakfast,Study Drug Dosing,Orthostatic blood pressure / pulse measurement - post dose,Adverse Event - 4 hours post dosing,Discharge
Itemgroups: Physical Examination,Complete Blood Count,NILOTINIB,Biochemistry,Electrocardiogram
Itemgroups: Administrative Documentation,Prior Medication,Prior Medication